LEADER 03896nam  22007215  450 
001 9910254349603321
005 20220520191449.0
010   $a981-10-0923-6
024 7 $a10.1007/978-981-10-0923-5
035   $a(CKB)3710000000765109
035   $a(DE-He213)978-981-10-0923-5
035   $a(MiAaPQ)EBC4602966
035   $a(PPN)194513521
035   $a(EXLCZ)993710000000765109
100   $a20160719d2017      u|         0
101 0 $aeng
135   $aurnn#008mamaa
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aTherapeutic and Diagnostic Nanomaterials /$fby Devasena T
205   $a1st ed. 2017.
210  1$aSingapore :$cSpringer Singapore :$cImprint: Springer,$d2017.
215   $a1 online resource (VII, 109 p. 25 illus., 2 illus. in color.)
225 1 $aNanotheranostics,$x2197-6740
311 0 $a981-10-0921-X 
320   $aIncludes bibliographical references at the end of each chapters.
327   $aDiagnostic and therapeutic nanomaterials -- Multifunctional Nanoparticles -- Biomarkers -- Diagnostic and therapeutic Techniques -- Toxicity and risk assessment -- In vitro and in vivo applications of selected nanomaterials.
330   $aThis brief highlights nanoparticles used in the diagnosis and treatment of prominent diseases and toxic conditions. Ecofriendly methods which are ideal for the synthesis of medicinally valued nanoparticles are explained and the characteristic features of these particles projected. The role of these particles in the therapeutic field, and the induced biological changes in some diseases are discussed. The main focus is on inflammation, oxidative stress and cellular membrane integrity alterations. The effect of nanoparticles on these changes produced by various agents are highlighted using in vitro and in vivo models. The mechanism of nanoparticles in ameliorating the biological changes is supported by relevant images and data. Finally, the brief demonstrates recent developments on the use of nanoparticles in diagnosis or sensing of some biological materials and biologically hazardous environmental materials.
410  0$aNanotheranostics,$x2197-6740
606   $aBiomedical engineering
606   $aBiomedical materials
606   $aMolecular biology
606   $aNanotechnology
606   $aMedical biochemistry
606   $aBiochemical engineering
606   $aBiomedical Engineering and Bioengineering$3https://scigraph.springernature.com/ontologies/product-market-codes/T2700X
606   $aBiomaterials$3https://scigraph.springernature.com/ontologies/product-market-codes/Z13000
606   $aMolecular Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/B1700X
606   $aNanotechnology and Microengineering$3https://scigraph.springernature.com/ontologies/product-market-codes/T18000
606   $aMedical Biochemistry$3https://scigraph.springernature.com/ontologies/product-market-codes/H35005
606   $aBiochemical Engineering$3https://scigraph.springernature.com/ontologies/product-market-codes/C12029
615  0$aBiomedical engineering.
615  0$aBiomedical materials.
615  0$aMolecular biology.
615  0$aNanotechnology.
615  0$aMedical biochemistry.
615  0$aBiochemical engineering.
615 14$aBiomedical Engineering and Bioengineering.
615 24$aBiomaterials.
615 24$aMolecular Medicine.
615 24$aNanotechnology and Microengineering.
615 24$aMedical Biochemistry.
615 24$aBiochemical Engineering.
676   $a610.28
700   $aDevasena T$4aut$4http://id.loc.gov/vocabulary/relators/aut$0946350
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910254349603321
996   $aTherapeutic and Diagnostic Nanomaterials$92138058
997   $aUNINA